DIA Bioventure Day
28 March 2017, Crown Plaza Glasgow, UK
DIA puts BioVentures in context!
DIA is excited to convene its 1st BioVenture Day. With the broad participation of many senior international health care experts, you will have a direct impact to improve Europe’s Biotech and Venture capital sectors for patients, investors, innovators, and practitioners.
Read more …
March 28th 2017
|8:00||Registration & Welcome Coffee|
|8:30 – 9:40||Welcome Remarks
Holger G Adelmann, Senior VP and Managing Director, DIA EMEA, Switzerland
|8:45||Keynote: Success Factors For Bringing A Product To The Market
Helga Ruebsamen-Schaeff, Chair Of The Board, Aicuris, Germany
|9:10||Session 1: Health System Financing And Reimbursement Of Innovation
Session 1 will set the scene for most of the day by exploring key challenges that the biotech-ecosystem, pharmaceutical innovators, and ultimately the patients that are expecting innovative cures are facing nowadays. Key stakeholders from the biotech industry, regulatory/payer area, and research in the economic & scientific policy field will share their recent insights and perspectives.
|11:00||Session 2: Innovative Funding Models
Session 2 will review innovative ways to fund private and public enterprises and to ensure patients with rare diseases are not being forgotten. Experienced Investors will share different approaches to fund innovative cure.
|12:30||Presentation & Discussion: EMA Health Care Pipeline White Spots Analysis – Opportunities for Bio-Ventures?
Agnès Saint Raymond, Head of International Affairs, European Medicines Agency, European Union
This presentation & discussion will be a rich source of inspiration for all health care stakeholders.
|14:00||Case Study Panel Discussion: Hepatitis C: Expensive Cure Versus Life-Long Suffering And Health Care Expenses
Moderator: Helga Ruebsamen-Schaeff, Chair of the Board, AiCuris, Germany
|16:00||Case Study Panel Discussion: Immuno-Oncology: Therapeutic Break Through Area Or Nightmare For Health Care Funding
Moderator: Duane Schulthess, Managing Director, Vital Transformation, Belgium
|17:30||Networking Reception & Moderated Poster Discussion
Topics for posters:
|19:30||End of the event|